Sanofi May Get EU Double Whammy After French Fine For Hindering Entry Of Plavix Generics
Executive Summary
Echoing the European Commission’s probe into whether drug companies blocked regional entry of cheaper generics, France’s Competition Authority has fined Sanofi €40.6 million for hindering domestic access to generic equivalents of its blockbuster clot-buster Plavix.